Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation
Allist Pharmaceuticals, Inc.
Allist Pharmaceuticals, Inc.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Shanghai Hengrui Pharmaceutical Co., Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
First Affiliated Hospital of Zhejiang University
Evopoint Biosciences Inc.